Form 4: UnitedHealth Group Director Stephen Hemsley Exercises Stock Options

Stephen J. Hemsley, a director at UnitedHealth Group, executed multiple transactions involving the exercise of non-qualified stock options and the subsequent disposition of shares to cover tax obligations on June 14, 2024.

Summary

• On June 14, 2024, Stephen J. Hemsley, a director at UnitedHealth Group, exercised non-qualified stock options.
• These transactions involved multiple tranches of options with exercise prices of $111.16, $160.31, $226.64, and $262.98.
• The total number of shares acquired through option exercises was 331,148.
• A portion of the acquired shares were then disposed of to satisfy tax obligations at prices of $496.83, $496.69, $496.86, and $496.66.
• After these transactions, Hemsley directly owns 810,539.942 shares of UnitedHealth Group common stock.
• Hemsley also indirectly owns shares through various GRATs and a 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider trading activity, with no inherent positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of company directors. It's a standard practice for executives to exercise stock options and sell a portion of the shares to cover taxes.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The vesting schedules of the options (25% annually over four years) are typical for executive compensation packages.
• Similar transactions are regularly seen among executives at companies like Johnson & Johnson (JNJ) and Pfizer (PFE).

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
• The filing provides transparency to shareholders regarding insider transactions.

Key Dates